Earlier, the US President Donald Trump asked India for the malaria drug Hydroxychloroquine saying that it can help to prevent the virus to some extent.
But now, he has changed his mind and said that he would rethink of using this drug to COVID-19 patients, and he will be making a statement on this soon.
The US government's National Institutes of Health has conducted a research on 368 COVID-19 patients. When a question asked by a reporter on the report given by NIH, Trump said the above statements.
The NIH report says that Hydroxychloroquine and Azithromycin are not working on the coronavirus patients, and the threat of mechanical ventilation is not lessened. It also said that many patients have died using these drugs as a cure.
But now, he has changed his mind and said that he would rethink of using this drug to COVID-19 patients, and he will be making a statement on this soon.
The US government's National Institutes of Health has conducted a research on 368 COVID-19 patients. When a question asked by a reporter on the report given by NIH, Trump said the above statements.
The NIH report says that Hydroxychloroquine and Azithromycin are not working on the coronavirus patients, and the threat of mechanical ventilation is not lessened. It also said that many patients have died using these drugs as a cure.